Cargando…
The Pharmacology, Efficacy, and Safety of Rivaroxaban in Renally Impaired Patient Populations
Rivaroxaban is a factor Xa inhibitor oral anticoagulant first approved for use in the United States in 2011. Under the drug class commonly termed direct oral anticoagulants, rivaroxaban is approved for the most indications within its class, 7 indications, which are: (1) reduction of risk of stroke a...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360104/ https://www.ncbi.nlm.nih.gov/pubmed/33599985 http://dx.doi.org/10.1002/jcph.1838 |